The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Rabeprazole Sodium 10 mg gastro-resistant tablets

10 milligram(s) Gastro-resistant tablet

Accord Healthcare Ireland Ltd.PA2315/139/001

Main Information

Trade NameRabeprazole Sodium 10 mg gastro-resistant tablets
Active SubstancesRabeprazole sodium
Strength10 milligram(s)
Dosage FormGastro-resistant tablet
Licence HolderAccord Healthcare Ireland Ltd.
Licence NumberPA2315/139/001

Group Information

ATC CodeA02BC Proton pump inhibitors
A02BC04 rabeprazole

Status

Authorised/WithdrawnAuthorised
Licence Issued09/02/2018
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusMarketed

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletNo document available
Public Assessment ReportNo document available

Generics Information

Interchangeable List CodeIC0015-002-005
Interchangeable List DocumentPDF of Interchangeable List
« Back